Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · Real-Time Price · USD
25.60
-0.41 (-1.58%)
Aug 28, 2026, 4:00 PM EDT - Market closed
Mineralys Therapeutics Employees
Mineralys Therapeutics had 76 employees as of December 31, 2025. The number of employees increased by 25 or 49.02% compared to the previous year.
Employees
76
Change (1Y)
25
Growth (1Y)
49.02%
Revenue / Employee
n/a
Profits / Employee
-$4,599,684
Market Cap
2.26B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 76 | 25 | 49.02% |
| Dec 31, 2024 | 51 | 23 | 82.14% |
| Dec 31, 2023 | 28 | 16 | 133.33% |
| Dec 31, 2022 | 12 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Sarepta Therapeutics | 835 |
| Maravai LifeSciences Holdings | 415 |
| Ocular Therapeutix | 325 |
| UroGen Pharma | 300 |
| Harmony Biosciences Holdings | 293 |
| Biohaven | 274 |
| Aurinia Pharmaceuticals | 128 |
| Mesoblast | 108 |
MLYS News
- 3 days ago - Mineralys Therapeutics to Participate in the Wells Fargo 21st Annual Healthcare Conference - GlobeNewsWire
- 12 days ago - Mineralys Therapeutics reports Q2 EPS ($2.85), consensus (54c) - TheFly
- 12 days ago - Mineralys Therapeutics price target lowered to $49 from $51 at BofA - TheFly
- 16 days ago - Mineralys Therapeutics Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 18 days ago - Mineralys Therapeutics Earnings Call Transcript: Q2 2026 - Transcripts
- 18 days ago - Mineralys Therapeutics Earnings release: Q2 2026 - Filings
- 18 days ago - Mineralys Therapeutics Quarterly report: Q2 2026 - Filings
- 18 days ago - Mineralys Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire